Review
doi: 10.1111/j.1365-2125.1984.tb02599.x.
The chemistry of enalapril
- PMID: 6085275
- PMCID: PMC1463492
- DOI: 10.1111/j.1365-2125.1984.tb02599.x
Item in Clipboard
Review
The chemistry of enalapril
Br J Clin Pharmacol.
1984.
Abstract
The design origins of the potent non-mercapto angiotensin converting enzyme inhibitors enalaprilat and its mono ethyl ester enalapril are described. Lactam analogues of enalaprilat have provided some insight into the conformation of this inhibitor when it is bound to converting enzyme. X-ray crystallographic studies of a related enzyme/inhibitor complex offer an explanation for the high potency and specificity of these and related inhibitors.
Similar articles
-
The design and properties of N-carboxyalkyldipeptide inhibitors of angiotensin-converting enzyme.Adv Enzymol Relat Areas Mol Biol. 1985;57:1-84. doi: 10.1002/9780470123034.ch1. Adv Enzymol Relat Areas Mol Biol. 1985. PMID: 2994404 Review.
-
Tissue angiotensin converting enzyme inhibition as an index of the disposition of enalapril (MK-421) and metabolite MK-422.J Pharmacol Exp Ther. 1983 Jul;226(1):192-6. J Pharmacol Exp Ther. 1983. PMID: 6306224 No abstract available.
-
Pharmacological properties of the new non-sulfhydryl angiotensin converting enzyme inhibitor N-[8-amino-1(S)-carboxyoctyl]-L-alanyl-L-proline.Arzneimittelforschung. 1990 May;40(5):515-9. Arzneimittelforschung. 1990. PMID: 2166521
-
Evaluation of angiotensin converting enzyme (ACE) in the pharmacokinetics and pharmacodynamics of ACE inhibitors.J Cardiovasc Pharmacol. 1986;8 Suppl 1:S9-14. doi: 10.1097/00005344-198600081-00003. J Cardiovasc Pharmacol. 1986. PMID: 2422495
-
Enalapril, a nonsulfhydryl angiotensin-converting enzyme inhibitor.Clin Pharm. 1985 Jan-Feb;4(1):27-40. Clin Pharm. 1985. PMID: 2982541 Review.
Cited by
-
Mechanisms underlying food-drug interactions: inhibition of intestinal metabolism and transport.Pharmacol Ther. 2012 Nov;136(2):186-201. doi: 10.1016/j.pharmthera.2012.08.001. Epub 2012 Aug 4. Pharmacol Ther. 2012. PMID: 22884524 Free PMC article. Review.
-
Evolution of diuretics and ACE inhibitors, their renal and antihypertensive actions--parallels and contrasts.Br J Clin Pharmacol. 1987;23 Suppl 1(Suppl 1):27S-41S. doi: 10.1111/j.1365-2125.1987.tb03120.x. Br J Clin Pharmacol. 1987. PMID: 3034317 Free PMC article.
-
Snake venom disintegrins update: insights about new findings.J Venom Anim Toxins Incl Trop Dis. 2023 Sep 18;29:e20230039. doi: 10.1590/1678-9199-JVATITD-2023-0039. eCollection 2023. J Venom Anim Toxins Incl Trop Dis. 2023. PMID: 37818211 Free PMC article. Review.
-
Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence.Vasc Health Risk Manag. 2016 Nov 15;12:443-451. doi: 10.2147/VHRM.S91020. eCollection 2016. Vasc Health Risk Manag. 2016. PMID: 27895487 Free PMC article. Review.
-
From Animal Poisons and Venoms to Medicines: Achievements, Challenges and Perspectives in Drug Discovery.Front Pharmacol. 2020 Jul 24;11:1132. doi: 10.3389/fphar.2020.01132. eCollection 2020. Front Pharmacol. 2020. PMID: 32848750 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
